Quantoom Biosciences SA
Ouverture de faillite 69.1 FTEThe score of Quantoom Biosciences shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2023
Change 2020 → 2023: Total assets +210 % Headcount (avg FTE) +172 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Quantoom Biosciences's annual accounts
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Revenue | €8.27m | |||
| Net result | −€14.2m | |||
| Equity | −€1.18m | |||
| Cash | €11.1m | |||
| EBITDA | −€9.25m | |||
| Total assets | €57.3m |
Filed annual accounts
- Year ended 31 Dec 2023filed on 04 Jul 2024
- Year ended 31 Dec 2022filed on 12 Jul 2023
- Year ended 31 Dec 2021filed on 22 Jul 2022
- Year ended 31 Dec 2020filed on 18 Jun 2021
Quantoom Biosciences's financial analysis
- Solvency-2.1%sector median: 34.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Quantoom Biosciences
11 active director(s) in the register.
and 5 more
Quantoom Biosciences's shareholders and holdings →Quantoom Biosciences's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0744.643.858
- VAT number
- BE0744643858
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 02 Mar 2020
- Registered office
- 1400 Nivelles
- Size
- Medium · 69.1 FTE
- Latest accounts
- 2023 · filed on 04 Jul 2024
- Activity
- Manufacture of medicaments (NACE 21201)
Quantoom Biosciences (SA) has been based in Nivelles since 2020, active in: manufacture of medicaments. For 2023, it reports revenue of €8.27m, a net loss of €14.2m and equity of −€1.18m. With 69.1 full-time equivalents, it is a medium-sized enterprise by headcount. Its solvency stands at -2.1%, below the median of its sector (34.4%).
Companies similar to Quantoom Biosciences
Companies in the same business, of comparable size and area, outside its group.
- Cellistic Manufacture of pharmaceutical preparations Mont-Saint-Guibert · balance sheet €41.6m
- Kaneka Eurogentec Manufacture of pharmaceutical preparations Seraing · balance sheet €115.4m
- S.M.B. Technology Manufacture of pharmaceutical preparations Marche-en-Famenne · balance sheet €56.8m
- Alcon Laboratories Belgium Manufacture of pharmaceutical preparations Puurs-Sint-Amands · balance sheet €107.2m
- Ogeda Research and experimental development on natural sciences and engineering Vilvoorde · balance sheet €53.5m
- Fujirebio Europe Manufacture of other chemical products n.e.c. Ghent · balance sheet €81.8m
- Odyssea Pharma Manufacture of pharmaceutical preparations Grâce-Hollogne · balance sheet €91.0m
- ELI Lilly European Clinical Trial Services Manufacture of medical and dental instruments and supplies Mont-Saint-Guibert · balance sheet €57.4m
Frequently asked questions about Quantoom Biosciences
What is the revenue of Quantoom Biosciences?
According to the 2023 annual accounts filed with the NBB, the revenue of Quantoom Biosciences amounts to 8,273,283 €.
What is the VAT number of Quantoom Biosciences?
In Belgium, the VAT number is the company number prefixed with BE: BE0744643858 for Quantoom Biosciences, if the company is VAT-registered. Its company number (CBE) is 0744.643.858.
Where is the registered office of Quantoom Biosciences?
According to the CBE register, the registered office of Quantoom Biosciences is in 1400 Nivelles.
What is the equity of Quantoom Biosciences?
At the close of the 2023 financial year, the equity of Quantoom Biosciences amounts to -1,176,622 €, a solvency of -2.1% of total assets.
How many people work at Quantoom Biosciences?
69.1 full-time equivalents on average according to the 2023 social balance sheet.
Who manages Quantoom Biosciences?
The register lists 11 active mandates at Quantoom Biosciences. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Quantoom Biosciences
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →